x
Filter:
Filters applied
- Regular Research Articles
- phosphatidylethanolamineRemove phosphatidylethanolamine filter
- phosphatidylinositolRemove phosphatidylinositol filter
- LPLATRemove LPLAT filter
Publication Date
Please choose a date range between 2021 and 2022.
Keyword
- arachidonic acid2
- lysophospholipid acyltransferase2
- PC2
- PE2
- PG2
- phosphatidylcholine2
- phosphatidylglycerol2
- PI2
- 1-acylglycerol-3-phosphate-O-acyltransferase1
- 31-deuterium-labeled palmitic acid1
- 35-deuterium-labeled stearic acid1
- 9-deuterium-labeled oleic acid1
- AA1
- ACC1
- ACL1
- AGPAT1
- AKT1
- ASO1
- ATP citrate lyase1
- C16:01
- C16:0-d 311
- C17:01
Regular Research Articles
2 Results
- Research ArticleOpen Access
Identification and characterization of LPLAT7 as an sn-1-specific lysophospholipid acyltransferase
Journal of Lipid ResearchVol. 63Issue 10100271Published online: August 29, 2022- Hiroki Kawana
- Masaya Ozawa
- Takeaki Shibata
- Hirofumi Onishi
- Yukitaka Sato
- Kuniyuki Kano
- and others
Cited in Scopus: 0The main fatty acids at the sn-1 position of phospholipids (PLs) are saturated or monounsaturated fatty acids such as palmitic acid (C16:0), stearic acid (C18:0), and oleic acid (C18:1) and are constantly replaced, like unsaturated fatty acids at the sn-2 position. However, little is known about the molecular mechanism underlying the replacement of fatty acids at the sn-1 position, i.e., the sn-1 remodeling. Previously, we established a method to evaluate the incorporation of fatty acids into the sn-1 position of lysophospholipids (lyso-PLs). - Research ArticleOpen Access
Hepatic deletion of Mboat7 (LPIAT1) causes activation of SREBP-1c and fatty liver
Journal of Lipid ResearchVol. 62100031Published online: February 5, 2021- Mingfeng Xia
- Preethi Chandrasekaran
- Shunxing Rong
- Xiaorong Fu
- Matthew A. Mitsche
Cited in Scopus: 0Genetic variants that increase the risk of fatty liver disease and cirrhosis have recently been identified in the proximity of membrane-bound O-acyltransferase domain-containing 7 (MBOAT7). To elucidate the link between these variants and fatty liver disease, we characterized Mboat7 liver-specific KO mice (Mboat7 LSKO). Chow-fed Mboat7 LSKO mice developed fatty livers and associated liver injury. Lipidomic analysis of liver using MS revealed a pronounced reduction in 20-carbon PUFA content in phosphatidylinositols (PIs) but not in other phospholipids.